NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 550 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | -57.1% | 550 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -30.0% | 550 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $10,000 | +11.1% | 550 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | -18.2% | 550 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $11,000 | +22.2% | 550 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $9,000 | 0.0% | 550 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | -91.4% | 550 | -87.9% | 0.00% | -93.2% |
| Q2 2020 | $105,000 | +707.7% | 4,550 | +506.7% | 0.04% | +528.6% |
| Q1 2020 | $13,000 | -18.8% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $16,000 | +14.3% | 750 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $14,000 | -33.3% | 750 | +25.0% | 0.01% | -36.4% |
| Q2 2019 | $21,000 | +5.0% | 600 | 0.0% | 0.01% | +10.0% |
| Q1 2019 | $20,000 | -87.8% | 600 | -88.0% | 0.01% | -89.7% |
| Q4 2018 | $164,000 | -10.4% | 5,000 | +66.7% | 0.10% | +1.0% |
| Q3 2018 | $183,000 | +72.6% | 3,000 | +200.0% | 0.10% | +47.7% |
| Q1 2018 | $106,000 | +47.2% | 1,000 | -66.7% | 0.06% | +35.4% |
| Q3 2017 | $72,000 | +22.0% | 3,000 | 0.0% | 0.05% | +23.1% |
| Q2 2017 | $59,000 | -15.7% | 3,000 | 0.0% | 0.04% | -22.0% |
| Q1 2017 | $70,000 | +89.2% | 3,000 | 0.0% | 0.05% | +66.7% |
| Q4 2016 | $37,000 | – | 3,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |